PrimeGenX Seeks Hong Kong IPO
The developer of anti-inflammatory treatments will need to persuade investors to look past its balance sheet problems and its narrow pipeline of products image credit: Bamboo Works Key Takeaways: The
PrimeGenX wants to sell shares on the Hong Kong stock market to raise money for its medicine company. Investors will watch whether the company can grow its treatments and fix its money troubles before deciding to invest.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.